Submission Details
| 510(k) Number | K143691 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 24, 2014 |
| Decision Date | January 28, 2015 |
| Days to Decision | 35 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K143691 is an FDA 510(k) clearance for the LDLC3 LDL-Cholesterol Gen.3, a Ldl & Vldl Precipitation, Hdl (Class I — General Controls, product code LBR), submitted by Roche Diagnostics Operations (Rdo) (Indianapolos, US). The FDA issued a Cleared decision on January 28, 2015, 35 days after receiving the submission on December 24, 2014. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1475.
| 510(k) Number | K143691 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 24, 2014 |
| Decision Date | January 28, 2015 |
| Days to Decision | 35 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | LBR — Ldl & Vldl Precipitation, Hdl |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 862.1475 |